Pain Management: Opioid and Controlled Substance Prescribing, New York State

The content will explore the complexities of opioid and controlled substances, emphasizing safety and adherence to legal and ethical guidelines. It covers the use of controlled substances and opioids for effective pain and comfort management along with important considerations for prescribing controlled substances and opioids related to palliative and end-of-life care.

After completing this learning activity, the participant should be able to:

• Explore recommended pharmacologic and nonpharmacologic treatment options for acute and chronic pain.
• Summarize guidelines and recommendations for safe prescribing of opioids.
• Identify available screening tools and factors to identify potential risk of substance use disorder.
• Outline the clinical criteria needed to confirm a diagnosis of substance use disorder.
• Indicate the purpose, benefits, and risks associated with medication-assisted treatment (MAT) in opioid use disorder.
• Identify key aspects of controlled substance and opioid prescribing in palliative care and hospice care.
• Identify specific New York state regulations for prescribing controlled substance/opioids.

3 AMA PRA Category I Credit(s)™

Prescribers licensed to treat humans and who have a Drug Enforcement Administration (DEA) number and medical residents prescribing under a facility DEA number. New York state relicensure requirements